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ABSTRAK 
_________________________________________________________________________ 
 
KECUKUPAN RAWATAN ANTIBIOTIK SECARA "EMPIRIKAL" KEPADA 
PESAKIT  YANG DIMASUKKAN KE UNIT RAWATAN RAPI AKIBAT "SEPSIS" 
 
Objektif : Sepsis merupakan salah satu penyebab utama kemasukan pesakit ke Unit 
Rawatan Rapi, Hospital Sultanah Nur Zahirah yang menyebabkan kematian dan 
komplikasi. Rawatan awal antibiotic secara "empirical" bagi pesakit yang mengalami sepsis 
adalah sangat penting untuk memperbaiki hasil rawatan . Matlamat kajian ini adalah untuk 
mengkaji kecukupan rawatan antibiotic secara "empirical" kepada pesakit-pesakit 'sepsis' 
yang dimasukkan ke Unit Rawatan Rapi, Hospital Sultanah Nur Zahirah, Kuala 
Terengganu. 
 
Metodologi : Kajian ini menggunakan kaedah retrospektif, untuk menilai kecukupan 
rawatan antibiotic secara "empirical" kepada pesakit yang dimasukkan ke Unit Rawatan 
Rapi disebabkan oleh sepsis. Seramai 130 orang pesakit yang sepsis yang dimasukkan ke 
Unit Rawatan Rapi pada 1 Januari 2013 hingga 31 Desember 2013 telah dipilih dan rekod 
perubatan mereka diambil melalui Sistem Informasi Hospital (HIS). Latarbelakang pesakit, 
penyakit, penggunaan antibiotic, keputusan ujian darah dan kesan terhadap pesakit dikaji. 
Penggunaan antibiotic empirical yang optimum ditentukan. Penggunaan antbiotik 
dikategorikan sebagai optimum apabila jenis antibiotic, dos, kaedah pemberian, dan tempoh 
rawatan adalah berdasarkan  panduan oleh Persatuan Rawatan Rapi Malaysia (MSIC). 
xii 
 
 
Keputusan : Seramai 119 (91.5%) orang pesakit daripada 130 pesakit sepsis yang 
dimasukkan ke Unit Rawatan Rapi telah menerima rawatan antibiotic secara "empirical" 
yang mencukupi. Dalam kumpulan ini, purata umur pesakit adalah 51.8 tahun dan 51.3 
peratus adalah lelaki. 112 (86.2%) pesakit mengalami 'septic shock' dan 104 (87.4%) 
daripadanya menerima rawatan antibiotic empirical yang optimum. Punca utama jangkitan 
kuman dalam darah bagi kumpulan ini adalah daripada paru-paru (42%), abdomen (21%) 
atau kulit dan tisu (15.1%). Kuman yang paling banyak menjangkiti pesakit adalah 
Escherichia coli 13 (37.1%), Burkholderia pseudomallei 7 (20.0%), Klebsiella pneumonia 
6 (17.1%), Acinobacter baumanii 4 (11.4%) dan Leptospira interrogan 2 (5.7%). Bagi 
pesakit yang dijangkiti kuman dari gram positif iaitu sebanyak 25 orang, kuman yang 
paling banyak adalah coagulase negative staphylococcus 11 (44.0%) dan staphylococcus 
aureus 11 (44.0%) diikuti oleh streptococcus pneumonia sebanyak 3 (12.0%) kes. Dalam 
kumpulan yang menerima rawatan optimum, kumpulan antibiotic yg paling banyak 
digunakan adalah cephalosporin,seramai 63 (52.9%) pesakit, carbapenem, 21 (17.6%) 
orang pesakit, diikuti oleh Piperacillin/tazobactam seramai 17 (14.3%) orang and 
Amoxycillin / clavulanic acid sebanyak 6 (5.0%) kes.  
Perbandingan antara kedua-dua kumpulan ini, didapati kesannya secara statistiknya adalah 
kurang meyakinkan. Ini termasuklah tempoh penggunaan alat bantuan pernafasan, tempoh 
rawatan hospital serta kematian. Walaupun begitu, didapati jumlah kematian adalah 
berkurangan sebanyak 10% apabila diberikan rawatan empirical antibiotic yang optimum. 
xiii 
 
Kesimpulan : Lebih daripada 90 peratus pesakit "sepsis" menerima rawatan antibiotik 
empirikal yang optimum. Antibiotik dari kumpulan 'cephalosporin' paling banyak diberikan 
kepada pesakit iaitu sebanyak 52.9 peratus manakala bagi pesakit yang menerima dua jenis 
antibiotik, kumpulan 'macrolide' merupakan antibiotic yang paling banyak diberikan. 
Didapati tiada perbezaan terhadap kesan kepada pesakit dalam kedua-dua kumpulan. 
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ABSTRACT 
 
ADEQUACY OF EMPIRICAL ANTIBIOTIC THERAPY FOR PATIENT 
ADMITTED TO ICU WITH SEPSIS 
 
Objectives: Sepsis is one of the commonest causes of ICU which lead to high mortality 
and morbidity. Early empirical antibiotic treatment is important to improve the patient's 
outcome . The aim of this study was to assess the adequacy of empirical antibiotic therapy 
for sepsis patients in Intensive Care Unit (ICU), Hospital Sultanah Nur Zahirah (HSNZ), 
Kuala Terengganu. 
 
Methods: This was a retrospective, observational study to evaluate the adequacy of 
empirical antibiotic given to patients who were diagnosed with sepsis in ICU. 130 cases 
who were admitted to ICU for sepsis from January 2013 to December 2013 were selected 
and their medical record were traced from HIS (Hospital Information System) and 
reviewed. Their demographic profiles, underlying comorbidities, antibiotic usage, culture 
and sensitivity results as well as patient’s outcome were reviewed. The adequacy of 
empirical treatment in each case was determined. Adequate empirical antibiotic treatment 
was considered adequate if spectrum, dose, application modus, and duration of therapy 
were appropriate according to MSIC (Malaysian Society of Intensive Care) guidelines. 
 
xv 
 
Results: Among 130 intensive care unit patients with sepsis, 119 (91.5%) received 
adequate antimicrobial treatment. In this group, the mean age of patients was 51.8 year old 
and 51.3% of them were men.112 (86.2%) patients presented with septic shock and 104 
(87.4%) of them were given adequate empirical antibiotic. The main sources of bacteremia 
in this group were from lungs (42%), abdomen (21%) or skin and soft tissue (15.1%). The 
microorganisms most frequently isolated were Escherichia coli 13 (37.1%), Burkholderia 
pseudomallei 7 (20.0%), followed with Klebsiella pneumonia 6 (17.1%), Acinobacter 
baumanii 4 (11.4%) and Leptospira interrogan 2 (5.7%). For patients with gram positive 
culture, which affected 25 patients with adequate treatment, coagulase negative 
staphylococcus, 11 (44.0%), and staphylococcus aureus, 11 (44.0%), were the most 
common organisms. This was followed with streptococcus pneumonia in 3 (12.0%) 
patients. Among the adequate group of patients, cephalosporin was the most frequently 
used, 63 (52.9%), carbapenem in 21 (17.6%) patients became the second option followed 
with Piperacillin/tazobactam in 17 (14.3%) patients and Amoxycillin / clavulanic acid 6 
(5.0%).  
Comparing both group of patients who received adequate and inadequate empirical 
antibiotics therapy, the outcome were not statistically significant in terms of the duration of 
ventilation and ICU stay, duration of hospitalization as well as patient mortality and 
survival. However there was 10% reduction of mortality in adequate treatment group. 
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Conclusion: More than 90 percent of patients with sepsis were given adequate empirical 
antibiotic treatment. The most common empirical antibiotic used was cephalosporin group 
(52.9%), whereas, macrolides was the most common second types of empirical antibiotics. 
However, there were no significant differences in term of outcome between adequate and 
inadequate group of therapy. 
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ICU stay, duration of hospitalization as well as patient mortality and survival. However there 
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CHAPTER 1 
_________________________________________________________________________ 
1.0 INTRODUCTION 
 
 Sepsis is the most common causes for ICU admission all over the world. During the 
previous 2 decades, the incidence of sepsis in the United States has tripled and is now the 
tenth leading cause of death. In spite of the use of antimicrobial agents and advanced life-
support, the mortality rate for patients with sepsis has remained between 20% to 30% 
during the past 2 decades. The first Surviving Sepsis Campaign (SSC) was introduced to 
improve the care of patients with severe sepsis and septic shock. It was launched by the 
Society of Critical Care Medicine, the European Society of Intensive Care Medicine and 
the International Sepsis Forum in 2002. The guidelines were updated once in 2008 with 85 
recommendations (Marik, 2011) . The latest update was in 2012.  
 
 Early antibiotic administration is one of the recommended therapies in the SSC 
guidelines.  The aim of therapy is the administration of effective intravenous antimicrobials 
within the first hour of recognition of septic shock and severe sepsis without septic shock 
(Dellinger et al., 2013). Important consideration when prescribing empirical antibiotics is 
the selection of an antibiotic that aims to be effective against any pathogen suspected of 
causing the infection(Swanson and Wells, 2013) . Empirical antibiotics are typically a 
broad-spectrum which can cover both gram- negative and gram- positive bacteria.  
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 Empirical antibiotic can be inadequate or adequate based on the in vitro 
susceptibilities of the identified pathogens (Swanson and Wells, 2013). Inadequate 
antimicrobials and delayed administration of adequate antimicrobial therapy associated 
with increase in mortality rate in sepsis patient (Lueangarun and Leelarasamee, 2012). 
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1.1 RATIONALE OF STUDY 
From this study, I hope that the results will give: 
 
 Information regarding adequacy of empirical antibiotics given to patients who were 
admitted to ICU with sepsis and also can give information regarding our adherence 
to the local antibiotics guidelines by MSIC (Malaysian Society of Intensive Care). 
 
 Knowledge regarding common organisms affected the sepsis patient and the 
common antibiotics given in sepsis patient. 
 
 
  Increase awareness among the clinician the importance of adequate empirical 
antibiotic in sepsis patients. 
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CHAPTER 2 
_________________________________________________________________________ 
2.0 LITERATURE REVIEW 
 
2.1 INFECTION 
 Infection is defined as the invasion of the body by pathogenic microorganisms that 
reproduce and multiply, causing disease by local cellular injury, secretion of a toxin, or 
antigen-antibody reaction in the host (Mosby, 2009) 
 
 The American College of Chest Physicians/Society of Critical Care Medicine 
(ACCP/SCCM) consensus committee approved a set of definitions to create a worldwide 
understanding including the bacteremia, SIRS, sepsis, severe sepsis and septic shock (Bone 
et al., 1992).  
 
2.2 BACTEREMIA 
 Bacteremia is the presence of viable bacteria in blood. The presence of viruses, 
fungi, parasites, and other pathogens in the blood should be described in a similar manner 
(ie viremia, fungemia, parasitemia, etc) 
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2.3 SIRS (Systemic inflammatory distress syndrome) 
 Systemic inflammatory response to various insults manifested by two or more of the 
following:  
 a)  temperature > 38
o
C or < 36
o
C,  
 b)  heart rate > 90 beats per minute,  
 c) tachypnea manifested by a respiratory rate > 20 breaths per minute or    
       hyperventilation as indicated by PaCO2 < 32mmHg 
 d) white blood cell count > 12000mm
-3
 , < 4000mm
-3
 or > 10% immature (band)     
     forms. 
 
2.4 SEPSIS 
 The systemic response to infection, manifested by two or more of the following as a 
result of infection: temperature > 38
o
C or < 36
o
C, heart rate > 90 beats/min, respiratory rate 
> 20breaths per minute, and white blood cell count > 12000mm
-3
, < 4000mm
-3
 or > 10% 
immature (band) forms 
 
2.5 SEVERE SEPSIS 
 Sepsis associated with organ dysfunction, hypoperfusion, or hypotension. 
Hypoperfusion and perfusion abnormalities may include, but not limited to lactic acidosis, 
oliguria, or an acute alteration in mental status. 
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2.6 SEPTIC SHOCK 
 Sepsis-induced with hypotension (systolic blood pressure, 90mmHg or a reduction 
of > 40mmHg from baseline in the absence of other causes for hypotension), despite 
adequate fluid resuscitation, along with the presence of perfusion abnormalities. These may 
include, but are not limited to, lactic acidosis oliguria or an acute alteration in mental status. 
Patients who are receiving inotropic or vasopressor agents may not be hypotensive at the 
time that perfusion abnormalities are measured. 
 
2.7 COMMUNITY- ACQUIRED INFECTION 
 Community acquired infection can be defined as an infection occurring in the 
community and manifest prior to hospital and ICU admission (Vincent et al., 1995; Valles 
et al., 2003) . In addition, all community acquired infections were required to be 
established within 48 hour of hospitalization (Kollef et al., 1999). Commonly involve 
strains of Haemophilus influenza or Streptococcus pneumonia and are usually more 
antibiotic sensitive (Harris and Nagy, 2009).   
  
 Community-acquired pneumonia (CAP) is associated with significant mortality and 
morbidity, especially in the elderly. For patient admitted with CAP, about 10% will require 
ICU admission. The mortality for severe CAP can be up to 20-50%. The causative 
pathogen remains unidentified in up to 60% of cases (Rello et al., 1993; Almirall et al., 
1995). 
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2.8 HOSPITAL-ACQUIRED INFECTION 
 Hospital- acquired infection of nosocomial infections refer to any systemic or 
localized conditions that result from the reaction by an infectious agent or toxin (Kouchak 
and Askarian, 2012). The infection occurring within 48 hours of hospital admission, 3 days 
of discharge or 30 days of an operation (Zaragoza et al., 2003; Path, 2005).  
  
 Health-care associated infection includes any patient who was hospitalized in an 
acute care hospital for two or more days within 90 days of the infection, resided in a 
nursing home or long-term care facility, received recent intravenous antibiotic therapy, 
chemotherapy, or wound care within the past 30 days of the current infection, or attended a 
hospital or hemodialysis clinic (Society and America, 2005).  
 
2.9 EARLY GOAL-DIRECTED THERAPY 
Early goal-directed therapy has been used for severe sepsis and septic shock in the 
intensive care unit. This approach includes adjustments of cardiac preload, afterload, and 
contractility to balance oxygen delivery with oxygen demand. 
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Figure 2.1: Protocol for Early Goal-Directed Therapy from Rivers et al. 
CVP denotes central venous pressure, MAP mean arterial pressure, and ScvO2    
            central venous oxygen saturation. 
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Two essential features of early goal-directed therapy include:  
1) maintaining an adequate central venous pressure (CVP) to carry out other 
hemodynamic adjustments  
2) maximizing mixed or central venous oxygen saturation (ScvO2)  
 
 The protocol was as follows. A 500-ml bolus of crystalloid was given every 30 
minutes to achieve a central venous pressure of 8 to 12 mm Hg. If the mean arterial 
pressure was less than 65 mm Hg, vasopressors were given to maintain a mean arterial 
pressure of at least 65 mm Hg. If the mean arterial pressure was more than 90 mm Hg, 
vasodilators were given until it was 90 mm Hg or below. If the central venous oxygen 
saturation was less than 70 percent, red cells were transfused to achieve a hematocrit of at 
least 30 percent. When the central venous pressure, mean arterial pressure, and hematocrit 
were thus optimized, if the central venous oxygen saturation was less than 70 percent, 
dobutamine administration was started at a dose of 2.5 μg per kilogram of body weight per 
minute,a dose that was increased by 2.5 μg per kilogram per minute every 30 minutes until 
the central venous oxygen saturation was 70 percent or higher or until a maximal dose of 
20 μg per kilogram per minute was given. Dobutamine was reduced in dose or stopped if 
the mean arterial pressure was less than 65 mm Hg or if the heart rate was more than 120 
beats per minute. To reduce oxygen consumption, patients in whom hemodynamic 
optimization could not be achieved received mechanical ventilation and sedatives. 
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       Following the bundle, once lactate is ≥4 mmol/L (36 mg/dL), or hypotension has 
been demonstrated to be refractive to an initial fluid challenge with 30 mL/kg of 
crystalloid, patients should then have their CVP maintained at ≥8 mm Hg. In adhering to 
this strategy, patients receive the initial minimum 30 mL/kg fluid challenge prior to 
placement of a central venous catheter and attempts to maximize CVP (Rivers et al., 2001). 
  
 The end points used to confirm the achievement of such a balance include 
normalized values for mixed venous oxygen saturation, arterial lactate concentration, base 
deficit, and pH.8. Mixed venous oxygen saturation has been shown to be a surrogate for the 
cardiac index as a target for hemodynamic therapy .In cases in which the pulmonary-artery 
catheter is not available, venous oxygen saturation can be measured in the central 
circulation (Tisherman et al., 2004). 
 
2.10 PHARMACOLOGY AND TYPES OF ANTIBIOTICS 
 Early administration of antimicrobial therapy is essential in sepsis patient especially 
before development of severe sepsis and septic shock (Brun-Buisson et al., 1995). 
Antibiotics can be defined as pharmacological agents that selectively kill or inhibit the 
growth of bacterial cells, while having little or no effect on human. Bacteriostatic 
antibiotics prevent further replication of bacteria, and therefore rely on an intact immune 
system to clear the infection, whereas bactericidal antibiotics kill the bacteria. . Cidal 
activity can sometimes be achieved by a combination of antibiotics (Varley et al., 2009). 
The pharmacokinetic and pharmacodynamics parameters will determine the ability of the 
11 
 
antibiotic to kill or inhibit the infective organism. Different antibiotic classes have different 
kill characteristics on bacteria as shown in figure 2 and table 1. There can be classified as 
concentration-dependent killing, time-dependent killing and both time-dependent with 
concentration- dependent killing. 
 
Figure 2.2: Pharmacokinetic and pharmacodynamic parameters of antibiotics on a 
concentration vs. time curve from Roberts and Lipman, 2009. 
 
 
Key words: T  MIC—The time for which a drug’s plasma concentration remains above the 
minimum inhibitory concentration (MIC) for a dosing period; Cmax/MIC, the ratio of the 
maximum plasma antibiotic concentration (Cmax) to MIC; AUC/MIC, the ratio of the area 
under the concentration time curve during a 24-hour time period (AUC0 –24) to MIC. 
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 The aminoglycosides and fluoroquinolones exhibit 'concentration-dependent killing' 
with peak concentration/MIC and AUC/MIC being the parameters that correlate with 
efficacy. For particular organism, these antibiotics also had prolonged antibiotic effects 
after the serum level decreases below the MIC. Larger doses result in greater efficacy and 
one-daily dosing for aminoglycosides maximizes the peak concentration/MIC. Different  
ratios have been found to be efficacious for different drug-bug combinations. For instance, 
for fluoroquinolones, the optimal AUC/MIC ratio for successful treatment of Streptococcus 
pneumonia is 25-35, whereas ratios 100 may be required for successful treatment of Gram-
negative bacilli. Greater AUC/MIC ratios are also less likely to be associated with 
development of resistance. 
 
 B-Lactam, erythromycin, clindamycin, and linezolid demonstrate 'time-dependent 
killing' with time/MIC become the most important index for efficacy. Thus, for these 
agents, the proportion of time above MIC is the most important parameter. AUC/MIC 
correlates  best with efficacy for azithromycin, tetracyclines, and glycopeptides (Varley et 
al., 2009).  
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Table 2.1: Pharmacodynamic properties that correlate with efficacy of selected antibiotics 
from Roberts and Lipman, 2009. 
_________________________________________________________________________ 
Antibiotics B-lactams         Aminoglycosides       Fluoroquinolones  
  Carbapenems          Metronidazole                      Aminoglycosides 
  Linezolid          Fluoroquinolones                 Azithromycin 
 
   Erythromycin   Telithromycin        Tetracyclines 
  Clarithromycin  Daptomycin         Glycopeptides 
  Lincosamides   Quinupristin/                     Tigecycline 
     dalfopristin   
               Quinupristin/ 
               dalfopristin 
               Linezolid 
PD kill  
characteristics   Time-dependent      Concentration-dependent     Concentration-dependent 
                with time-dependence 
 
Optimal PD   T >MIC   Cmax:MIC    AUC0–24:MIC 
Parameter 
 
MIC, minimum inhibitory concentration; AUC, area under curve; PD, pharmacodynamics; 
Cmax, maximum concentration. 
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2.11 PRINCIPLES OF EMPIRICAL ANTIMICROBIAL THERAPY 
 Empirical antibiotic should be guided by the most likely site of infection and likely 
organisms. All appropriate microbiological specimens including blood cultures should be 
taken before starting the antibiotics whenever possible. Besides associated with poor 
outcomes, inappropriate antimicrobial therapy can lead to the emergence of resistant 
organisms, antimicrobial-related adverse events as well as increase in healthcare costs. 
 
 
 When initiating appropriate empirical antibiotics in patients with severe sepsis, few 
factors must be consider including the likely causative organisms, patient factors and 
properties of antibiotics. 
 
1) Likely causative organism 
 Decide either community or health-acquired infection 
 Identify the most likely source of infection 
 Consider local epidemiological data: types of antibiotic depend on the local 
susceptibility pattern. Knowing the resistance profiles in the community, hospital or 
unit helps in choosing antimicrobials appropriately 
 
 
2) Patient factors 
 Severity of illness i.e. patient with severe sepsis or septic shock require broad 
spectrum antibiotics 
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 Prior antibiotic use or prolonged hospitalization. Both factors associated with 
presence of resistant organisms. 
 Immunosuppressive states (malignancy, malnutrition, on steroid or 
immunosuppressive drugs) may require broad-spectrum therapy including 
antifungal. 
 Presence of renal or hepatic dysfunction. The risk-benefit of the antimicrobial must 
be determined on a case-to-case basis. Maintenance doses are adjusted according to 
the severity of organ dysfunction. 
 Others : pregnancy or any drug allergy 
 
 
3) Antimicrobial profile 
 
 Route of administration. 
 The intravenous route should always be used in severe sepsis as oral absorption is 
 unpredictable even in drugs with good oral bioavailability. 
 Dose and interval. 
 Pathophysiological changes in critically ill patients alter the pharmacokinetic (PK) 
 and pharmacodynamic (PD) profile of the antimicrobials. Antibiotics can be 
 categorized into three different classes depending on the PK/PD indices associated 
 with their optimal killing activity. 
 Achievable antimicrobial concentrations in tissue. 
 Aminoglycosides and glycopeptides have poor tissue penetration. Thus, 
 aminoglycosides should not be used as monotherapy while a higher plasma level of 
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 glycopeptides is recommended to ensure adequate tissue penetration. Both ß-
 lactams and quinolones have good tissue penetration. 
 Post antibiotic effect (PAE) 
 This is defined as persistent suppression of bacterial growth even after the serum 
 antibiotic concentration falls below the MIC of the target organism. For examples,  
 aminoglycosides and fluoroquinolones have post antibiotic effect against gram 
 negative bacteria. 
 Adverse events 
 Risk-benefit of antimicrobials with potential serious adverse events should be 
 considered which depend on cases. If unavoidable, serum levels should be 
 monitored for toxicity (e.g. aminoglycosides). 
 Ecological profile 
Limit the use of antimicrobials with known potential for selecting resistant 
organisms and associated risks of superinfection e.g. third generation 
cephalosporins (selection pressure for ESBL producing Enterobacteriaceae). 
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 Empirical antibiotic therapy should be re-evaluated after 48-72 hours or when 
culture results become available. Once a causative pathogen is identified, the spectrum of 
antimicrobial therapy should be narrowed (de-escalation). If the patient is improving, the 
recommended duration of antibiotic therapy is 5 to 7 days. There is increased risk of 
resistance with prolonged use of antibiotics. Certain conditions may require prolonged 
therapy e.g infective endocarditis. Consider change to the oral route whenever possible. 
 
 If there is no clinical response within 48-72 hours, need to rule out: 
 The possibility of a secondary infection 
 The presence of resistant organisms 
 Abscess that are not drained or infected foreign bodies that are not removed 
 Inadequate penetration of antimicrobial to the site of infection 
 Inadequate spectrum of antibiotic coverage 
 Inadequate dosage or interval 
 Non-infectious causes e.g. deep vein thrombosis, acute myocardial or pulmonary 
infarctions, acute pancreatitis, hyperthyroidism, Addisonian crisis, malignancies and 
central nervous system haemorrhages (Chan et al., 2012). 
  
 
. 
 
 
 
 
18 
 
2.12 SURVIVING SEPSIS CAMPAIGN (SSC) 
International guidelines for management of severe sepsis and septic shock. The 
initial SSC guidelines were published in 2004. The most current iteration is based on 
updated literature search incorporated into the evolving manuscript through fall 2012 
(Dellinger et al., 2013). It recommends a six hour resuscitation bundle and a 24 hour 
management bundle to improve outcomes in severe sepsis. 
 
2.13 HSNZ and ICU 
Hospital Sultanah Nur Zahirah (HSNZ), Kuala Terengganu formerly known as 
Kuala Terengganu Hospital. This hospital is located nearby famous Batu Burok Beach, 
which covered land area of 21.09 hectares. Until year 2014, HSNZ has 821 beds, 28 wards, 
9 specialist clinics, 16 operation theatres, 13 delivery theatres and 1 delivery operational 
theatre as well as 19 clinical specialists. HSNZ has 2,400 staffs.  
 
 It is the biggest hospital in Terengganu and become the main referral centre of the 
state. Their intensive care unit (ICU) has 20 beds and able to accommodate up to 18 
ventilated patients. This study was done in ICU HSNZ. 
 
 Since 2011, this hospital was using HIS (Health Information System) where all 
patients’ information was available in the computer system. This system was designed to 
improve access to patient information through a central electronic information system. 
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HIS's goal is to streamline patient information flow and its accessibility for doctors and 
other health care providers. These changes in service will improve patient care quality  and 
patient safety over time. 
 
 The system provides all record patient information, patient laboratory test results, 
and patient's doctor information. Doctors can access easily person information, test results, 
and previous prescriptions. Every staff was provided with their identification code to assess 
the system. For Intensive Care Unit and operation theatre, on top of HIS system, they are 
providing with CCIS (Critical Care Information System) which provides the data for 
continuous patient monitoring. 
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CHAPTER 3 
_________________________________________________________________________ 
3.0 METHODOLOGY 
 
3.1 OBJECTIVES 
3.1.1 GENERAL OBJECTIVES 
 The aim of this study was to evaluate the usage of empirical antibiotic for sepsis 
patients in Intensive Care Unit (ICU), Hospital Sultanah Nur Zahirah (HSNZ). 
 
3.1.2 SPECIFIC OBJECTIVES 
 To determine the adequacy of empirical antibiotic administration for sepsis 
patients in ICU, HSNZ, from 1
st
 January-31
st
 December 2013. 
 To determine the frequency of commonly prescribed empirical antibiotic for 
sepsis patient in ICU.  
 To evaluate the impact of adequate empirical antibiotic therapy on the 
outcome of patients. 
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3.2 STUDY DESIGN 
 This study was a non-interventional, cross-sectional study, based on retrospective 
analysis of data collection. The data were obtained from the CCIS (critical care information 
system) including patient’s medical notes, drug chart, and laboratory results. This study 
was conducted after obtaining the ethical approval from the Medical Research and Ethics 
Committee, Ministry Of Health, Malaysia. 
 
3.3 CHARACTERISTICS OF SUBJECTS 
3.3.1 INCLUSION CRITERIA 
 Adult patients with the age of 18 year old and above 
 All patients who fulfilled the criteria of sepsis on admission to ICU 
 All patients who received antibiotics within the first 6 hours of ICU 
admission 
 
3.3.2 EXCLUSION CRITERIA 
 Patients with underlying immunodeficiency i.e. malignancy, neutropenia, 
HIV positive etc.  
 Patient with second episode of sepsis 
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3.4 DETERMINATION OF SAMPLE SIZE  
 The sample size for this study is determined using a single proportion formula 
(Lwanga and Lemeshow, 1991). This formula used to estimate the adequacy of empirical 
antibiotics used for sepsis patient in ICU HSNZ with 95% confidence interval. 
n = (z/^)
2
 * P(1-P)   
p = anticipated patients proportion is 91% (MacArthur et al., 2004) 
z= value is1.96, for the level of confidence of 95% 
d=absolute precision required on the either side of the proportion, taken at 5% to an 
adequate sample size 
Using the formula,  
n = (1.96/0.05)
2
 x 0.91 (1-0.91) = 126 samples 
10% drop out = 14 samples 
The calculated sample size required was 140. 
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3.5 SAMPLING METHOD 
 This study involved all patients who were admitted to Intensive Care Unit, HSNZ 
from 1
st
 January 2013 until 31
st
 December 2013 which met the inclusion and exclusion 
criteria. Lists of patients admitted to ICU with sepsis were collected from ICU admission 
book. Then, registration numbers of the eligible patient were collected and patient’s 
medical record were traced from the HIS (Hospital Information System) and reviewed 
retrospectively. Patients' data were collected from medical records, medication charts as 
well as investigation results. There were 190 patients who fulfilled the inclusion criteria. 
All patients were listed following the sequence of admission from January until December. 
140 consecutive patients were selected for the sampling but 10 of the record were missing, 
incomplete or cannot be traced. Therefore, only 130 patients were analyzed.  
 
3.6 DATA COLLECTION 
 We collected all the data as below: 
 Patient demographic data 
 Underlying medical illness 
 Diagnosis upon ICU admission 
 Primary site of infection 
 Presence of septic shock 
 Empirical antibiotic in ICU, dosage and duration 
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 Culture and sensitivity results 
 Antibiotic outcome (de-escalate, change or continue) 
 Duration of ICU admission 
 Duration of hospitalization 
 Patient outcome i.e. alive or death 
 Empirical antibiotic was considered adequate when the isolated organism was sensitive 
or intermediate in sensitivity to at least one of the antibiotic which was given within 24 
hours of ICU admission. For patients with polymicrobial infection, all the pathogens 
must sensitive to the antibiotics. Patient without any organism isolated also considered 
as adequate. The antibiotic was adequate in terms of spectrum, dose, application modus 
and duration of therapy based on guidelines from the Malaysian Society of Intensive 
Care. 
 Inadequate antibiotic was considered when the spectrum, dosage, application modus of 
antibiotics, or the duration of therapy, and/or when the isolated pathogenic bacteria 
were resistant to the antibiotic. 
 
3.7 DEFINITIONS 
 Empirical antibiotic defined as the initial antibiotic regimen started within 24 hours 
of admission before the culture results are available (Mettler et al., 2007).  
 
 Infection-directed treatment was defined as the administration of antimicrobials for 
a specific clinically localized source of (e.g., pneumonia, urinary tract, wound, and 
bloodstream). Clinically localized sources of infection, excluding bloodstream 
